4.8 Article

CKAP2L Promotes Non-Small Cell Lung Cancer Progression through Regulation of Transcription Elongation

期刊

CANCER RESEARCH
卷 81, 期 7, 页码 1719-1731

出版社

AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-20-1968

关键词

-

类别

资金

  1. CRUK core grant [C5759/A20971]
  2. Lung Cancer Centre [C5759/A20465]

向作者/读者索取更多资源

CKAP2L has been identified as a potential oncogene that promotes lung cancer proliferation by directly interacting with RNA Pol II to regulate transcription elongation of key genes involved in various cellular pathways. Inhibiting CKAP2L could enhance therapeutic response in patients with NSCLC by increasing sensitivity to specific inhibitors and reducing cell proliferation.
Chromosomal instability (CIN) is a driver of clonal diversification and intratumor heterogeneity, providing genetic diversity that contributes to tumor progression. It is estimated that approximately 80% of solid cancers, including non-small cell lung cancer (NSCLC), exhibit features of CIN, which affects tumor growth and response to therapy. However, the molecular mechanisms connecting CIN to tumor progression are still poorly understood. Through an RNAi screen performed on genes involved in CIN and over-expressed in human lung adenocardnoma samples, we identified the cytoskeleton-associated protein 2-like (CKAP2L) as a potential oncogene that promotes lung cancer proliferation and growth in vitro and in vivo. Mechanistically, CKAP2L directly interacted with RNA Pol II and regulated transcription elongation of key genes involved in spindle assembly checkpoint, chromosome segregation, cell cyde, and E2F signaling. Furthermore, depletion of CKAP2L increased the sensitivity of NSCLC cells to alvocidib, a pan-CDK inhibitor, leading to a significant reduction of cell proliferation and an increase in cell death. Altogether, these findings shed light on the molecular mechanisms through which CKAP2L, a protein involved in CIN, promotes cancer progression and suggest that its inhibition represents a novel therapeutic strategy in NSCLC. Significance: These findings demonstrate the oncogenic function of CKAP2L through regulation of transcription elongation and suggest that targeting CKAP2L could enhance therapeutic response in patients with NSCLC.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据